URSA-PHARM-101: Oral Antidiabetic PDC

Measure Description

Among patients with a continuous period of plan membership of 180 days or longer in the 12 months prior to a snapshot date, and with 2 or more antidiabetic medication fills during that membership period, the percentage of days between the first qualifying fill and the earlier of the snapshot date or membership period end date with positive supply of antidiabetic medication.

Metadata

• Measure Type: Rate Measure
• Temporal Structure: Entity
• Component Class: Long-Form
• Denominator Case Field: Patient ID
• Target Direction: Up

Denominator Description

One per qualifying patient.

Numerator Description

The antidiabetic medication PDC for the period from the first qualifying fill to the snapshot date or the end of the continuous membership period, whichever comes first.

Related Key Concepts

None.

FAQs

None.